Sreetama Dutt

Sreetama Dutt

B.Tech. Biotechnology Engineering, M.Sc. Medical Microbiology

Sreetama Dutt has completed her B.Tech. in Biotechnology from SRM University in Chennai, India and holds an M.Sc. in Medical Microbiology from the University of Manchester, UK. Initially decided upon building her career in laboratory-based research, medical writing and communications happened to catch her when she least expected it. Of course, nothing is a coincidence.

See more

Sreetama has always been passionate about writing. As a child she would always scribble in any random piece of paper she got, be it scrap paper, a notebook, or her grandfather’s brand new organizer, all she ever needed was a pen. And this somehow stayed with her for as long as she can remember.

Sreetama started freelancing right after completing her master’s degree. Mingling her passion for writing and her core subject matters seemed to be the best career path for her. As a part of her first assignment, she authored and co-authored multiple articles, news reports, press releases, and blogs for online news channels. The thought of connecting with people through her work and spreading the word on the latest in healthcare, pharmaceuticals and technology gave her immense joy.

For the past 7 years, there has been no looking back for Sreetama. From being employed in various start-ups, working on niche areas like ophthalmology and oncology, to working with entrepreneurs and innovators, independently, Sreetama has found herself authoring every form of document – be it abstracts, white papers, website content, articles, newsletters, and peer-reviewed publications. Sreetama has 5 peer-reviewed publications so far, in reputed journals, with more to come.

In her free time, Sreetama enjoys dancing, music, and reading. She loves to explore new places and meet new people. On a day off, you will find her exploring new cafés in the city, looking up the latest in fashion, or snuggling in a blanket with a book in hand.

See less

Articles from Sreetama

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

Curious case of SARS-CoV-2 Delta variant in a dog

Curious case of SARS-CoV-2 Delta variant in a dog

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Taking lessons in molecular therapeutics from earthworms to combat COVID

Taking lessons in molecular therapeutics from earthworms to combat COVID

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

Study shows enhanced immunogenicity of heterologous boosting strategy in individuals primed with J&J vaccine

Study shows enhanced immunogenicity of heterologous boosting strategy in individuals primed with J&J vaccine

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.